ALOX15B and atherosclerosis: It is known that 20:4 ChE acts as a substrate for oxidizing agents, such as 12- or 15-lipoxygenase; thus, the metabolites generated by 20:4 ChE are associated with atherosclerosis and modulation of the anti-inflammatory response cascade [45].